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Background: Overuse of antibiotics for upper respiratory tract infections (URIs) and acute bronchitis is a persistent
and vexing problem. In the U.S., more than half of all patients with upper respiratory tract infections and acute
bronchitis are treated with antibiotics annually, despite the fact that most cases are viral in etiology and are not
responsive to antibiotics. Interventions aiming to reduce unnecessary antibiotic prescribing have had mixed results,
and successes have been modest. The objective of this evaluation is to use mixed methods to understand why a
multi-level intervention to reduce antibiotic prescribing for acute bronchitis among primary care providers resulted
in measurable improvement in only one third of participating clinicians.
Methods: Clinician perspectives on print-based and electronic intervention strategies, and antibiotic prescribing
more generally, were elicited through structured telephone surveys at high and low performing sites after the first
year of intervention at the Geisinger Health System in Pennsylvania (n = 29).
Results: Compared with a survey on antibiotic use conducted 10 years earlier, clinicians demonstrated greater
awareness of antibiotic resistance and how it is impacted by individual prescribing decisions—including their own.
However, persistent perceived barriers to reducing prescribing included patient expectations, time pressure, and
diagnostic uncertainty, and these factors were reported as differentially undermining specific intervention
components’ effectiveness. An exam room poster depicting a diagnostic algorithm was the most popular strategy.
Conclusions: Future efforts to reduce antibiotic prescribing should address multi-level barriers identified by
clinicians and tailor strategies to differences at individual clinician and group practice levels, focusing in particular
on changing how patients and providers make decisions together about antibiotic use.
Keywords: Antibiotics, Clinician practice patterns, Patient education, Quality improvementBackground
Overuse of antibiotics for upper respiratory tract infec-
tions (URIs) and acute bronchitis is a persistent and vex-
ing problem. Although the large majority of URIs and
acute bronchitis cases are viral in etiology and therefore
not responsive to antibiotics [1-3], more than half of all
patients with these illnesses are treated with antibiotics
every year in the U.S. [4,5]. Unnecessary antibiotic use for
acute bronchitis is associated with increased risk of ad-
verse drug events, higher overall health care costs, and* Correspondence: sara.ackerman@ucsf.edu
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reproduction in any medium, provided the orincreased patient and population level risk of drug resist-
ant infections [6-8]. As a result, the rate of antibiotic use
for patients with acute bronchitis is included as a HEDIS
(Healthcare Effectiveness Data and Information Set) qual-
ity performance measure by the independent National
Committee for Quality Assurance (NCQA) and reported
by the vast majority of health insurers in the U.S. [5].
Attempts to reduce unnecessary antibiotic use have had
mixed results. A combination of patient and physician edu-
cation has been shown to help reduce antibiotic overuse
for a variety of acute respiratory tract infections, including
acute bronchitis [4,5], but levels of improvement have been
limited, on average, to less than 20% absolute reduction
across the study populations of physicians [9-12]. Some ofral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ducted in Europe. All have focused on improving clini-
cians’ communication skills, and the most successful have
combined communication skills training with point-of-care
testing for C reactive protein and the use of interactive
booklets during consultations with patients [13-16]. Over-
all, antibiotic prescribing for acute bronchitis has been
more resistant to change than for other acute respiratory
infections, and the large majority (up to 90%) of patients
diagnosed with acute bronchitis continue to be prescribed
antibiotics [17-19].
Explanations for the intractability of antibiotic overuse
for acute bronchitis include diagnostic uncertainty re-
garding the presence of alternative antibiotic-responsive
illnesses (e.g., pneumonia), patient expectations in a so-
cietal context of consumer-oriented medicine and wan-
ing professional sovereignty among physicians, and time
demands that favor expedient management decisions
[20,21]. However, few studies have specifically explored
whether these factors are barriers to effective implemen-
tation of interventions designed to reduce inappropriate
antibiotic prescribing.
A three-armed cluster randomized trial of a multidi-
mensional intervention strategy to reduce antibiotic pre-
scribing for acute bronchitis was conducted at 33 primary
care practice sites within the Geisinger Health System in
Pennsylvania. Intervention sites received either print-
based or electronic medical record (EMR)-based clinical
decision support strategies in the form of treatment algo-
rithms, in addition to patient education brochures and
provider education seminars on appropriate prescribing
practices.
Overall, the intervention resulted in a 12% absolute re-
duction in antibiotic prescribing (changes at EMR-based
and print-based sites did not differ significantly), while
prescribing rates increased slightly at the control sites
[22]. Closer inspection of individual prescribing patterns
showed that about 30% (N = 21) of clinicians decreased
their prescribing rates substantially whereas the remaining
two-thirds demonstrated variation in levels of prescribing
that was no different from the control group. Based on
available clinician characteristics, we did not find signifi-
cant differences between the clinicians who changed their
prescribing practices and those who did not.
To explore this clinician-level dichotomy in intervention
response further, we investigated individual attitudes to-
wards the intervention among clinicians at high and low
performing sites, and considered these responses in the
context of recent historical changes in clinician percep-
tions of antibiotic use more broadly. We conducted a
mixed methods study using a computer-assisted telephone
interviewing (CATI) instrument to assess physician atti-
tudes towards antibiotic prescribing, and we compared
the results with those of a similar survey conducted in2000, in order to assess secular changes in physician atti-
tudes towards antibiotic prescribing. We also asked open-
ended questions to identify possible patient, clinician and
practice-level reasons for the variability in the interven-
tion’s impact, specifically focusing on reasons for the inter-
vention’s failure to influence the prescribing behaviors of
the majority of clinicians who were exposed to it.
Methods
The cluster randomized trial involved 33 practices allo-
cated equally to an EMR-based intervention, print-based
intervention and control group [22]. For this survey study
of a subset of practices, we sought to ensure equal repre-
sentation of providers from practices with high and low
antibiotic prescribing rates following the intervention. We
invited all primary care clinicians (physicians, physician
assistants, and nurse practitioners) practicing at the three
practices with the highest antibiotic prescribing rates and
the three practices with the lowest prescribing rates (based
on the acute bronchitis HEDIS measure), for each of the
print and EMR-based intervention arms of the trial, to
participate in the study. High performing EMR-based
intervention practices had an overall antibiotic prescribing
rate of 33%, whereas low performing EMR-based interven-
tion practices had an overall prescribing rate of 78%. At
high performing print-based intervention practices, the
prescribing rate was 55%, compared with 86% at low per-
forming print-based intervention practices.
A total of 55 clinicians were recruited at the 12 interven-
tion practices. At print-based practices, the intervention
consisted of a poster depicting a diagnostic algorithm for
cough illness that was placed in all examination rooms
(see Figure 1). At EMR-based practices, a similar algo-
rithm was programmed into the health system’s electronic
medical record and clinicians were provided with an
“order set” that recommended selected tests and treat-
ments based on the specific diagnosis resulting from appli-
cation of the algorithm (ie, acute bronchitis, sinusitis, URI,
pneumonia).
All practices received patient education brochures with
information about appropriate antibiotic use for cough
and cold illness from the U.S. Centers for Disease Control
[6]. The brochures were distributed by the nurse at the
check-in desk of each clinic for any patient registering
with a chief complaint of cough. No specific training was
provided on the use of the brochures. Clinician “cham-
pions” were also assigned to each practice and invited to
attend a training session led by R.G. and J.P.M., which
included a lecture and small group discussion on the
drivers of antibiotic prescribing in primary care settings
and strategies for reducing patient expectation and anti-
biotic prescribing. The sessions were divided by EMR- and
print-based intervention sites in order to include an orien-
tation to the actual decision support tools.
EVIDENCE-BASED MANAGEMENT OF 





Among elderly patients: 
Also consider pneumonia when altered mental 
status (clouded thinking), increased falls, loss of 
appetite or new urinary incontinence is present.
LOW
(< 5%)
No abnormal vital signs 
and normal chest exam
INTERMEDIATE
(5% - 30%)
One or more abnormal 




One or more abnormal 





ABx based on CXR results
Perform CXR
Consider empiric ABx**
* CXR should be ordered on all patients with focal lung findings on physical examination.
** Abnormal vital signs are common with uncomplicated influenza infection when influenza is circulating in the community.
In the absence of pneumonia, consider the following 




cough plus nasal, 







  wheezing common
Influenza
Dx criteria
if cough + fever + 
  myalgias/fatigue 





illness > 7 days
purulent nasal 
  discharge
facial, head or teeth 
  pain
The above algorithm is derived from clinical practice guidelines endorsed by the AAFP, ACP-ASIM, CDC and IDSA.
This algorithm is designed to assist the clinician in the management of acute cough illness.  The recommendations herein are not 
intended to replace a clinician’s judgement or to establish a protocol for all patients with a particular condition.
Figure 1 Exam room poster.
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were asked to provide clinician education sessions and peri-
odic feedback about prescribing practices for front line pro-
viders at their site. The content of these sessions included
an educational slide set, provided by the study team and
covering decision rules for appropriate antibiotic use, aswell as tool-specific training. The sessions were held at the
beginning of the intervention period and varied in size from
one-on-one to small groups. Providers were aware that
their prescribing practices were being monitored and that
they would be invited to participate in a survey at the end
of the study period. Providers were contacted by staff
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the telephone survey at the end of the first year of the
intervention.
Trained interviewers conducted the survey by telephone.
Closed- and open-ended questions on three topics were
included: 1) individual and societal consequences of anti-
biotic overuse; 2) barriers to improving antibiotic prescrib-
ing; and 3) perceived effectiveness of specific intervention
components. Several of the questions in categories 1) and
2) were duplicated from a survey on attitudes towards
antibiotic prescribing conducted with a national sample of
primary care physician a decade earlier [23]. In addition,
we added questions regarding perceived barriers to redu-
cing antibiotic prescribing, including diagnostic uncer-
tainty and patient expectations (see Additional file 1 for
survey instrument). Closed-ended survey questions were
measured on a five-point Likert scale and responses to
open-ended questions were transcribed or paraphrased in
writing by the interviewer. Responses were de-identified
using a coding system with access restricted to the inter-
viewers and authors.
The study was approved by the Geisinger Health System
Institutional Review Board (IRB). For the clinical trial (re-
ported separately), informed consent was not obtained from
any patients or parents because the IRB determined that
the quality improvement intervention focused on improv-
ing adherence to standards of care and did not require indi-
vidual subject consent. The participant interviews with
clinicians required verbal informed consent at the start of
the interview. The IRB granted a waiver for written in-
formed consent.
Quantitative survey data were summarized with
frequency distributions, collapsing “strongly agree” and
“agree” categories for each item. Unadjusted comparisons
across groups were conducted with Chi-square test (or
Fisher’s Exact test when cell sizes < 5 observations), com-
paring providers in both intervention arms and at high
and low performing sites with each other and intervention
providers with the historical control group. The constant
comparative method was used for qualitative data analysis
and integration of qualitative and quantitative results [24].
This process involved repeated reading and discussion of
the survey responses by the study team in order to extract
key themes. The triangulation of open- and closed-ended
survey responses was conducted by comparing responses
within and across individual respondents in order to dis-
cern patterns or associations. Survey responses for which
associations between open- and closed-ended questions
were not found are reported separately.
Results
A total of 29 clinicians completed the survey (53% re-
sponse rate), including 26 MD/DOs, 2 nurse practitioners,
and 1 physician assistant. Nine respondents were fromEMR-based intervention practices and 20 were from print-
based intervention practices; 16 were from high performing
sites and 13 were from low performing sites. There were 14
female and 15 male respondents, and on average they had
practiced medicine at the Geisinger Health System for
8 years.
Individual and community consequences of
antibiotic overuse
Overall, 97% of respondents from the intervention practices
agreed that antibiotic resistance is a major public health
problem, and 93% believed that over-prescribing of antibi-
otics is a major cause of antibiotic resistance (Table 1). In
the 2000 survey of primary care physicians, a similar major-
ity (82%) of respondents agreed that antibiotic resistance is
a major public health problem.
Similarly, when asked to reflect on the importance of in-
dividual prescribing decisions, both their own and among
clinicians more generally, all respondents in the current
study concurred that each individual decision to prescribe
antibiotics has an impact on community antibiotic resist-
ance, compared with 75% agreement with the same state-
ment 10 years earlier. An even more pronounced change
was evident in responses to the statement, “I prescribe an-
tibiotics more often than I should,” with 36% agreement in
2000 and 66% in 2010. On the other hand, it should be
noted that in 2000 and 2010, 30% and 31% of respondents,
respectively, reported that they themselves did not over-
prescribe antibiotics.
Barriers to improving antibiotic prescribing
Participants in the trial identified several perceived bar-
riers to practice change at multiple, interacting levels
(Table 2). One of the most enduring was the belief that pa-
tients want antibiotics and will not be satisfied if they are
not offered them. Most (79%) of the clinicians in the
current survey reported that their patients really want and
expect antibiotics, and will be dissatisfied if they don’t get
them (72%).
Several clinical and economic factors also appeared to
serve as barriers to reducing inappropriate antibiotic pre-
scribing. These include insufficient time with each patient,
a problem that a notable minority (41%) of respondents
reported was characteristic of their practice; a concern
expressed by 34% of respondents about medical liability in
the event that antibiotics are not prescribed and there is a
bad outcome; and the challenging task of explaining med-
ical evidence to patients. Indeed, a sizable proportion
(38%) of respondents agreed that it is easier to give pa-
tients antibiotics than to explain that they don’t work.
Clinicians also reported diagnostic uncertainty and lack
of generalizability of randomized controlled trial-based evi-
dence as barriers to improving antibiotic prescribing. Spe-
cifically, 48% reported that they could not always trust
Table 1 Clinicians’ attitudes towards antibiotic prescribing over time
Survey question 2000 (n = 400)
% Agree




Antibiotic resistance is a major public health problem. 82 97 0.0415
Over-prescribing antibiotics is a major cause of antibiotic resistance. 86 93 0.402
I am confident that the development of new and effective drugs will
keep pace with the growing rate of antibiotic resistance.
21 17 0.813
Each individual decision to prescribe antibiotics has an impact on antibiotic resistance. 75 100 0.0005
I prescribe antibiotics more often thanI should. 36 66 0.003
Ackerman et al. BMC Health Services Research 2013, 13:462 Page 5 of 9
http://www.biomedcentral.com/1472-6963/13/462chest x-ray results to rule out pneumonia, and 21% be-
lieved that randomized trials that found no benefit of anti-
biotics for acute bronchitis do not adequately represent
patients in their practice.
Clinicians’ responses to the intervention
Open-ended survey responses did not reveal meaningful
differences by site (high vs. low HEDIS performance) in
providers’ attitudes and perceptions of the intervention,
but they did demonstrate considerable variation among
individual clinicians in terms of how the intervention
was received. Different opinions about the intervention
may be related to individual clinicians’ perception of the
problem of antibiotic overuse more broadly, and may
point to possible reasons for the wide variability in the
intervention’s effectiveness. This topic will be discussed
in more detail below.
Both positive and negative assessments of both the print-
based and EMR-based interventions highlight the import-
ance of responsiveness to practice change initiatives in
shaping how intervention components were received and
acted on. For example, respondents appeared to fall into
two categories of receptivity to practice change initiatives:
those who think they cannot, or do not need to, change
and those who appreciate being reminded of the need to
change. Respondents in the first group reported that they
were familiar with the message about reducing antibiotic
prescribing prior to participating in the intervention, that
antibiotic prescribing was already low at their site, or thatTable 2 Clinicians’ perceived barriers to improving performan
Information Set) acute bronchitis measure in 2010 (N = 29)
Survey question
My patients really want and expect antibiotics when they come in.
My patients will be dissatisfied if they don’t get antibiotics.
It’s easier to just give the patient antibiotics than to explain that they don’t w
I can’t always trust the CXR results to rule out pneumonia.
The randomized trials that found no benefit of antibiotics for acute bronchiti
not adequately represent patients in my practice.
I don’t have enough time with each patient.
I worry about possible medical liability if I don’t prescribe antibiotics and the
Prescribing antibiotics for acute bronchitis is standard of care.education is unlikely to change patients’ expectations. Re-
spondents in the second group were more likely to inter-
pret the intervention as a kind of continuing education
opportunity, as in the following statement: “It reminded
you when antibiotic use would be more appropriate.”
Interestingly, receptivity to the intervention was not corre-
lated with any particular responses to the closed-ended
survey questions.
In the following sections, we summarize in more de-
tail the perceived weaknesses and strengths of the
interventions.
Intervention weaknesses
By far the most common clinician-reported obstacle to re-
ducing antibiotic prescribing—one that most respondents
insisted was not adequately addressed by the intervention—
was patients’ expectations with regard to antibiotics. For ex-
ample, both the on-site education session and patient bro-
chure were critiqued by many respondents for their
apparent inability to persuade patients (or help clinicians to
persuade patients, in the case of the clinician education
component) that antibiotics may not be the appropriate
treatment for their condition. Participants emphasized that
patients did not appear to read the brochure, did not “take
in” its information, or “did not feel the brochure pertained
to them.” In addition, as one clinician put it, a patient’s
“mind has already been set [that they need antibiotics] be-
fore they see the doctor.” “They just want to leave with
medication,” said another, suggesting that the brochuresce on the HEDIS (Healthcare Effectiveness Data and
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propriate use of antibiotics.
In addition, a majority of clinicians said that the EMR-
based decision aid did not help them to influence pa-
tients’ expectations regarding antibiotics. “If the patient
has in their mind that they absolutely need the anti-
biotic, they will leave with one,” said one clinician when
asked about the EMR-based decision aid. Similarly, a mi-
nority of respondents did not approve of the print-based
aid because they thought that it was not an effective
medium for changing patients’ expectations. “Posters
don’t change people’s minds,” said one clinician. Nor
was it tailored to individual patients’ circumstances, as
mentioned in this comment: “People think that the post-
ers do not pertain to them.” These findings corroborate
the closed-ended survey responses reported earlier, in
which the majority of clinicians agreed that their pa-
tients want and expect antibiotics and will be dissatisfied
if they do not receive them.
Another important factor in limiting participants’ re-
sponse to the intervention was the perceived role that
they, as individuals or groups of clinicians, play in anti-
biotic overprescribing and how amenable their routine
clinical practices are to change. For example, some re-
spondents suggested that overprescribing was not a
problem at their site, and that the on-site education ses-
sion presented by the clinic champion was therefore not
necessary and might be more appropriate for clinics with
“doctors giving out antibiotics like chewing gum.” Sev-
eral participants reported that education on appropriate
prescribing is unlikely to change “longstanding prescrib-
ing habits”, while others claimed that the clinicians at-
tending the session were already familiar with the
information presented. Although we did not find a sig-
nificant correlation between these respondents and the
nearly one third who disagreed with the statement “I
prescribe antibiotics more than I should,” it is notable
that both open and closed-ended survey questions re-
vealed a subset of clinicians who do not feel that they
are part of the problem of overprescribing.
Bearing out the results of the Likert-scale survey de-
scribed above, the belief that evidence-based guidelines
are not applicable to all patients, and uncertainty about
correct diagnosis, are additional lenses through which
respondents evaluated specific intervention components.
For example, one clinician reported that the EMR deci-
sion tool and diagnostic algorithm could not be relied
on because “guidelines don’t take into account the com-
plexity of evaluating an individual patient.” Another clin-
ician questioned the on-site education session content,
stating that key indicators of pneumonia are not always
apparent on an x-ray and that there may be reasons to
be more aggressive with treatment that do not appear in
the decision tool’s diagnostic criteria.A final weakness of the intervention related to workflow.
The majority opinion was that the requirements of the
EMR-based decision aid, in particular, made it cumber-
some and difficult to use, and that it undermined existing
work processes. As one clinician put it, “It was too much
for a simple order. I can just talk to a patient for five mi-
nutes and decide what is wrong, rather than go through
the entire process and reach a different conclusion.” Sev-
eral clinicians reported selectively using the electronic tool
or not using it at all because it was “too long and compre-
hensive” or “too difficult to use.” In short, the clinical ad-
vantages of the EMR-based intervention did not outweigh
its workflow disadvantages for the majority of respon-
dents, particularly in comparison with the exam room
poster. As one clinician reported about the EMR-based
intervention “By the time you got to diagnose the problem
it didn’t change anything for me.”Intervention strengths
The print-based decision aid was positively reviewed by the
majority of surveyed clinicians for its usefulness when dis-
cussing diagnosis and treatment with patients. For example,
the poster was praised for its simple visual depiction of the
symptoms for which antibiotics are and are not indicated.
Several clinicians described gesturing to the poster as a kind
of “backup” expert when explaining prescribing decisions
to patients. The poster was also reported to be a useful and
accessible educational tool whose message about appropri-
ate antibiotic use was made more persuasive by its clearly
labeled affiliation with the medical center and the state de-
partment of health. Providing support for clinicians’ efforts
to persuade patients that they do not need antibiotics may
be particularly valuable in the exam room, particularly con-
sidering that the majority of our respondents believe that
their patients will be dissatisfied if they leave without
antibiotics.
Although the EMR-based decision aid was subject to
more negative than positive comments, some clinicians
reported that this component of the intervention made
them follow “a more factual process” and “apply criteria”
before prescribing antibiotics, and that it encouraged
“good medical decision making”. Overall, the evidence-
based, standardized approach to diagnosis and treatment
that characterized the decision aid was perceived as im-
proving clinical reasoning among some clinicians and
undermining the clinical autonomy of others.
Finally, for some respondents the intervention did im-
prove workflow. For example, several clinicians reported
that the clinician education session and the print and EMR
versions of the decision tool served as useful prompts or re-
minders about appropriate prescribing criteria, correct
diagnostic codes for bronchitis, and the “true symptoms” of
viral and bacterial infections.
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Previous research has demonstrated that antibiotic pre-
scribing is shaped by clinical, economic and social factors
that coalesce in a “culture of prescribing”, whose norms
enable the continuation of undesirable practices despite
concerted efforts to change them [25-27]. Our results sug-
gest that there has been some improvement in the culture
of antibiotic prescribing for cough illness in the U.S. over
the past 10 years, particularly in terms of a growing aware-
ness among primary care clinicians of the scope and mag-
nitude of antibiotic resistance, and of the contribution of
individual prescribing decisions to the problem.
Nevertheless, the interventions evaluated here were not
robust enough to make a more than modest impact on
overall prescribing for acute bronchitis, and it was clear
that they had a much stronger impact on some clinicians
and clinical practice sites than others. Other studies have
found significant variability in prescribing practices both
geographically and among individual clinicians, which ap-
pears to be the result of clinical and non-clinical contextual
factors that are resistant to change or beyond the scope of
targeted interventions [28,29]. In our study, nearly a third
of respondents did not believe that they overprescribed an-
tibiotics even though their actual prescribing rates were on
average as high as those of clinicians who report overpre-
scribing (data not shown). A better understanding of the
causes of clinicians’ (mis)perception is a requisite step in
the design of a tailored intervention for this particular
group, since the most effective approach for clinicians who
acknowledge overprescribing and want to change their pre-
scribing practices is likely to be different from approaches
that will be successful with clinicians who do not acknow-
ledge their own participation in the problem.
The belief that patients want and expect antibiotics was
another key factor that appeared to undermine the inter-
vention components’ perceived effectiveness, and that
showed persistence over time in the 2000 and 2010 sur-
veys. If patient expectations were thought to remain un-
altered by the use of a decision aid (even if the aid
specifically targeted the physician rather than the patient),
then that intervention component was deemed less useful.
Educational brochures, for example, were considered in-
capable of changing patients’ beliefs about antibiotic ef-
fectiveness for cough illness. Previous research suggests
that printed educational materials for patients and/or pro-
viders have little effect on their own, but that they
are more effective when used to guide communication
between clinician and patient or when paired with verbal
advice by a clinician [12,13,15,30-33]. This may be because
social context, including the patient-clinician relationship,
plays a more powerful role in shaping prescribing deci-
sions than does information or algorithms that are ab-
stracted from the interactive context of a medical decision
[34,35]. Therefore, training clinicians to engage patients ina discussion about appropriate antibiotic use may be a
more effective strategy for changing patient expectations
than brochures or clinical practice guidelines alone.
Another example of the importance of patient-clinician
interactions is the perception among respondents that the
exam room poster was a more useful tool in discussions
with patients than the EMR-based decision aid. From one
point of view, the poster’s popularity as a persuasive com-
munication device is at odds with its inability to influence
overall prescribing rates more than the other intervention
components. However, its limited success reinforces the
need for strategies that assist clinicians with diagnosis and
treatment discussions with patients. Indeed, prior research
highlights the ambivalence experienced by clinicians as
they attempt to balance their own “individual best prac-
tice” criteria with patient expectations, in particular when
patient desires conflict with professional opinion [36,37].
Future attempts to change prescribing practices should
engage both patients and clinicians during the clinical en-
counter, and should be flexible enough to assist and enable
clinicians with different communication styles and degrees
of experience to anticipate and respond to a range of ex-
plicit or tacit requests for antibiotics from patients [38].
Our findings also suggest variability in clinicians’ beliefs
about how to navigate the complex intersection of
evidence-based criteria and the specificity of an individual
patient’s condition. For some of our participants this
meant that their own clinical judgment should be able to
overrule evidence-based practice guidelines, policies, or
decision aid recommendations. For others these same
guidelines and decision aids were perceived as an import-
ant source of assistance and professional improvement,
but only if they did not interfere with clinical or adminis-
trative procedures. For nearly all respondents, a tool that
was perceived as unwieldy, time-consuming, or undermin-
ing of existing work processes, was unlikely to be widely
adopted. In the future, decision support tools for antibiotic
prescribing should strike a balance between promoting
practice change and supporting individual clinicians’
modes of balancing clinical and population-level evidence.
Our study did not have a large-enough sample size to de-
tect whether differences in perceived barriers to improving
antibiotic prescribing help explain differences in clinicians’
responses to the intervention. Nor were we able to discern
whether variations in perceived barriers accounted for pre-
scribing differences at high and low performing interven-
tion sites. Moreover, the survey responses in the table were
drawn from two distinctly different studies. The small sam-
ple size, geographic specificity, and single institutional affili-
ation of our study’s participants may not be generalizable to
primary care clinicians nationally, whereas the 2000 survey
was conducted with a larger national sample of internists
and family practice physicians. In addition, the 2000 survey
was conducted anonymously by mail, whereas our survey
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through an intensive, hands-on intervention, so the re-
sponses reported here may have been influenced by expos-
ure to intervention materials and staff.
Conclusions
A growing literature on strategies to reduce the overuse of
antibiotics demonstrates that multifaceted interventions
tend to be the most successful [12,39]. Our results also
suggest that efforts to reduce antibiotic prescribing may
be more effective if they intervene directly in the clinical
encounter and attend to key differences among individual
clinicians and group practices. A nuanced assessment of
the reasons for practice variation – both among individual
clinicians and between group practices – could be used to
determine which change strategies would be most appro-
priate for groups of clinicians with similar prescribing pat-
terns, and how these interventions should be adjusted to fit
the specific clinical and social contexts in which patients
and clinicians come together and make decisions [40].
To work towards this goal, we recommend a more tai-
lored approach to the problem of overprescribing—one
that draws on social and behavioral science theory and
methods to guide research and intervention design. This
would include: a) in-depth, qualitative and quantitative as-
sessments of how context—specifically norms, values, re-
lationships and resources, produce variations in the
impact of interventions aiming to improve antibiotic pre-
scribing; b) adapting intervention design to different
groups of providers using, for example, the social market-
ing strategy of “audience segmentation” [41]; and c) build-
ing flexibility and responsiveness into the design of change
strategies so that interventions can be adjusted mid-
stream based on clinician and patient feedback.
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